Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-08-30FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approves Upsher-Smith's generic diltiazem hydrochloride through an original ANDA (ANDA205231) for use as a calcium channel blocker.
-
FDA approval · 2018-08-28FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
The FDA approved a supplemental application for Losartan Potassium Tablets, 25 mg from Jubilant Cadista Pharmaceuticals, authorizing this ge…
-
FDA approval · 2018-08-17FDA Approved: SODIUM NITROPRUSSIDE — Original Application (Somerset Therapeutics, LLC)
FDA approved the original ANDA for Sodium nitroprusside from Somerset Therapeutics, LLC, authorizing a generic IV vasodilator for use in hyp…
-
FDA approval · 2018-08-16FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Sandoz's generic benazepril hydrochloride and hydrochlorothiazide combination, validating its us…
-
FDA approval · 2018-08-08FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for benazepril hydrochloride and hydrochlorothiazide, submitted by Padagis US LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-08-08FDA Approved: LASIX — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for LASIX (furosemide) from Validus Pharmaceuticals LLC.
-
FDA approval · 2018-08-01FDA Approved: ENALAPRIL MALEATE — Supplemental Application (OCEANSIDE PHARMACEUTICALS)
FDA approved a supplemental application for enalapril maleate from Oceanside Pharmaceuticals, indicating an updated/expanded labeling for th…
-
FDA approval · 2018-07-30FDA Approved: NITROGLYCERIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Nitroglycerin submitted by Prasco Laboratories, signaling an approval-related action affecting t…
-
FDA approval · 2018-07-30FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for benazepril hydrochloride (generic) filed by Amneal Pharmaceuticals of New York LLC. This action …
-
FDA approval · 2018-07-23FDA Approved: NADOLOL — Original Application (UNICHEM PHARMACEUTICALS (USA), INC.)
FDA approved Nadolol as an original application from Unichem Pharmaceuticals (USA), Inc., establishing a generic nadolol product.
-
FDA approval · 2018-07-20FDA Approved: AVALIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Avalide (irbesartan and hydrochlorothiazide) from Sanofi-Aventis U.S. LLC.
-
FDA approval · 2018-07-20FDA Approved: AVAPRO — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for AVAPRO (irbesartan) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2018-07-19FDA Approved: QUINAPRIL — Supplemental Application (BluePoint Laboratories)
FDA has approved a supplemental application for Quinapril submitted by BluePoint Laboratories. The action updates the regulatory status of t…
-
FDA approval · 2018-07-18FDA Approved: SPIRONOLACTONE — Original Application (Zydus Lifesciences Limited)
FDA approved the Original Application (ANDA) for spironolactone from Zydus Lifesciences Limited, marking a generic version of the diuretic.
-
FDA approval · 2018-07-13FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal's VERAPAMIL HYDROCHLORIDE as an original ANDA generic product.
-
FDA approval · 2018-06-29FDA Approved: NIFEDIPINE — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for Nifedipine from Zydus Lifesciences Limited, a generic calcium channel blocker used for hypertensio…
-
FDA approval · 2018-06-29FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved the original application for Triamterene and Hydrochlorothiazide from Zydus Pharmaceuticals (USA) Inc., a generic fixed-dose co…
-
FDA approval · 2018-06-29FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (ScieGen Pharmaceuticals, Inc.)
FDA approved the original ANDA for olmesartan medoxomil, a generic angiotensin II receptor blocker for hypertension. The approval confirms a…
-
FDA approval · 2018-06-18FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)
The FDA approved the original application for Verapamil Hydrochloride by Somerset Therapeutics, LLC, enabling a generic version of verapamil…
-
FDA approval · 2018-06-18FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)
FDA approves Somerset Therapeutics' Verapamil hydrochloride as an original application, granting a generic version of the drug.
-
FDA approval · 2018-06-08FDA Approved: QUINAPRIL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Quinapril Hydrochloride from Aurobindo Pharma Limited. This approval pertains to the generic…
-
FDA approval · 2018-06-08FDA Approved: ESMOLOL HYDROCHLORIDE IN SODIUM CHLORIDE — Original Application (Mylan Institutional LLC)
FDA approved esmolol hydrochloride in sodium chloride injection (ANDA) from Mylan Institutional LLC for short-term control of heart rate in …
-
FDA approval · 2018-06-08FDA Approved: ESMOLOL HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)
FDA approved esmolol hydrochloride injection as an original generic application from Sagent Pharmaceuticals.
-
FDA approval · 2018-05-25FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for a fixed-dose combination of amlodipine and atorvastatin (amlodipine bes…
-
FDA approval · 2018-05-24FDA Approved: CHLORTHALIDONE — Original Application (Nivagen Pharmaceuticals, INC.)
FDA approved CHLORTHALIDONE from Nivagen Pharmaceuticals as an original generic application.